Target intelligence / Profile preview

Mitochondrial ribosomal protein S17 pseudogene 3 (MRPS17P3)

Target
MRPS17P3
Molecular classification
Other (Pseudogene)
01

Overview

Mitochondrial ribosomal protein S17 pseudogene 3 (MRPS17P3) is classified as a pseudogene in the human genome[5][1]. Pseudogenes are genomic DNA sequences similar to known genes but typically noncoding and nonfunctional due to mutations or lack of regulatory sequences required for expression[1][5]. MRPS17P3 is derived from the mitochondrial ribosomal protein S17 gene family but does not produce a protein product and is not involved in any known biological processes or diseases; it serves as a genomic relic rather than an active molecule[1][5][9]. MRPS17 is a protein-coding gene that encodes a small subunit protein of the mitochondrial ribosome, essential for mitochondrial protein synthesis[4][7]. By contrast, MRPS17P3 is one of several pseudogenes related to MRPS17, lacking protein-coding capability and biological function. There are no therapeutic implications, disease associations, biomarkers, mechanisms of action, or known safety concerns for MRPS17P3, as it is not an active gene or protein[1][5][9]. Its presence in molecular databases is primarily for annotation completeness and genomic studies; it does not act as a receptor, enzyme, transporter, transcription factor, or any other classical drug target[1][5][9].

Other names
Ribosomal protein S17 pseudogene 3RPS17P3RPS17BRPS17L2RPS17_7_1537

Beyond the preview

Go deeper on Mitochondrial ribosomal protein S17 pseudogene 3 (MRPS17P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein S17 pseudogene 3 (MRPS17P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call